Continuous Health Concerns Over Oral Contraceptives
A recent New York Times article documents the health concerns of the popular oral contraceptives, Yasmin and Yaz. The article points out that although these two contraceptives were at the top of Bayer’s sales chart, they do come with some increased risks over other oral contraceptives.
Bayer promoted Yaz not only as a birth control method, but as a way to combat acne and severe premenstrual depression. Bayer was required to change their advertising earlier this year, as they were accused of making false claims on the benefits of the pill. They were also cited for not following quality control procedures when manufacturing the pill.
The age at which girls begin taking birth control is gradually decreasing, making them the main target of campaign ads. It is so frustrating to me to learn that these large drug companies are putting products on the market without properly disclosing their adverse side effects. Think of your daughter, sister, niece, friends- they need to hear about the harmful side effects of oral contraceptives.
Please view the New York Times article and check out the comments section. There are many powerful accounts of women that have been affected by Yaz.
We at Drug Alert Updates would love to help you if you or someone you know have been affected by using Yaz. Please contact us with any questions you may have.
December 3, 2009
Tags: Bayer Pharmaceuticals, birth control, side effects Posted in: Yasmin/YAZ
Leave a Reply